Search
for
Sort by
Research 901–930 of 1000+
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Post-finasteride syndrome: An emerging clinical problem
- Adverse health effects of androgen use
- Skin health and integrity
- Lifestyle Drugs in Old Age – A Mini-Review
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Stingless bee propolis promotes hair follicle regeneration and melanocyte function in chemotherapy-induced alopecia mouse model
- <i>De Novo</i> Design of Anti-Aging Peptides
- CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Nutritional management in women with polycystic ovary syndrome: A review study
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Cronkhite-Canada syndrome: A rare disease presenting with dermatological and gastrointestinal manifestations
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- A CASE REPORT: SUSPECT PSYCHOGENIC ALOPECIA WITH SECONDARY DERMATITIS IN A PERSIAN CAT
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Alopecia androgenética en varones jóvenes: un indicador clínico temprano de resistencia a la insulina
- Yale–New Haven Hospital top contender in Abbott quality awards
- Stem cells and aberrant signaling of molecular systems in skin aging
- Diseases of Periocular Hair
- Trichotillomania and Traction Alopecia
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata